Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059262) titled 'Efficacy of 12-week continuous application lipids derived from animal at two dosage levels on scalp barrier function' on Oct. 6.

Study Type: Interventional

Study Design: Cross-over Randomized

Primary Sponsor: Pharma Foods International Co.,Ltd

Condition: no

Intervention: Duration: one week 0.001% lipids derived from animal Solution Duration: one week 0.01% lipids derived from animal solution...

Recruitment Status: Not Recruiting

Phase: Not applicable

Date of First Enrollment: 2025/10/06

Target Sample Size: 13

Countries of Recruitment: Japan

To know more, visit https://center6.umin.ac.jp/cgi...